Browse the full record of transactions filed by Secora Michael, Chief Financial Officer. Officer active across 1 company, notably Recursion Pharmaceuticals, INC.. Cumulatively, 3 disclosures have been published. Activity tracked since 4 February 2022. The latest transaction was filed on 16 May 2022 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
3 of 3 declarations
Michael Secora is the Chief Financial Officer of RECURSION PHARMACEUTICALS, INC. In this role, he is responsible for the financial management of the company, including budgeting and performance analysis. His expertise in the pharmaceutical sector is essential in supporting RECURSION's growth strategy. He also plays a key role in optimizing financial resources and ensuring regulatory compliance.